Health economics in the field of osteoarthritis: an expert's consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).

Date publication

décembre 2013

Journal

Seminars in arthritis and rheumatism

Auteurs

Membres identifiés du Cancéropôle Est :
Pr GUILLEMIN Francis

Tous les auteurs :
Hiligsmann M, Cooper C, Arden N, Boers M, Branco JC, Luisa Brandi M, Bruyère O, Guillemin F, Hochberg MC, Hunter DJ, Kanis JA, Kvien TK, Laslop A, Pelletier JP, Pinto D, Reiter-Niesert S, Rizzoli R, Rovati LC, Severens JL, Silverman S, Tsouderos Y, Tugwell P, Reginster JY

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/23992801

Résumé

There is an important need to evaluate therapeutic approaches for osteoarthritis (OA) in terms of cost-effectiveness as well as efficacy.

Mots clés

Consensus, Cost of Illness, Cost-Benefit Analysis, Evidence-Based Medicine, economics, Humans, Osteoarthritis, economics, Quality of Life

Référence

Semin. Arthritis Rheum.. 2013 Dec;43(3):303-13